Samsung Biologics

Samsung Biologics, headquartered in Songdo, South Korea, is a premier, rapidly growing Contract Development and Manufacturing Organization (CDMO) that has fundamentally disrupted the global biomanufacturing landscape through unprecedented scale and extraordinary speed. Backed by the immense industrial, financial, and engineering prowess of the Samsung Group, the company was established in 2011 and has quickly become a dominant force in the healthcare industry. Samsung Biologics specializes deeply in the bulk, large-scale production of mammalian cell culture-based therapeutics, particularly complex monoclonal antibodies (mAbs) and recombinant proteins.

The company offers fully integrated, end-to-end biomanufacturing services ranging from early cell line development and clinical-stage manufacturing to massive commercial-scale production and highly sterile aseptic fill-finish operations. In addition to its mastery of mammalian biomanufacturing, Samsung Biologics has aggressively expanded its capabilities into advanced modalities, launching dedicated facilities for mRNA vaccine production and, most recently, antibody-drug conjugates (ADCs) to support highly specialized next-generation oncology therapeutics.

Operationally, Samsung Biologics is globally renowned for its unique ability to architect, build, and validate biomanufacturing “mega-plants” in record time while maintaining absolute quality control. The company operates primarily out of its massive bio-campus in Songdo, which houses some of the largest and most technologically advanced biologic facilities in the world. With the completion of its 240,000-liter ‘Super Plant’ (Plant 4) in Bio Campus I and the rapid operationalization of Plant 5 in the new Bio Campus II, the organization offers unparalleled capacity, pushing toward a staggering total capacity of over 1.3 million liters to directly address global biological drug shortages.

Characterized by its uncompromising commitment to flawless regulatory compliance, rapid technology transfer, and massive scale, Samsung Biologics operates with supreme efficiency. By combining cutting-edge digitalization with unmatched manufacturing muscle, the company remains a highly sought-after, indispensable partner for biopharmaceutical companies seeking to bring life-saving therapies to market reliably and at a massive global scale.